3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
12
Prostatic Neoplasms
11
Oropharyngeal Neoplasms
10
Lung Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Breast Neoplasms
9
Glioma
8
Urinary Bladder Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Esophageal Neoplasms
6
Neoplasm Metastasis
5
Mouth Neoplasms
5
Carcinoma
5
Burkitt Lymphoma
5
Astrocytoma
5
Sarcoma
4
Pancreatic Neoplasms
4
Laryngeal Neoplasms
4
Gliosarcoma
4
Carcinoma, Hepatocellular
4
Brain Neoplasms
4
Adenocarcinoma of Lung
4
Adenocarcinoma Of Esophagus
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Rhabdomyosarcoma, Embryonal
3
Rhabdomyosarcoma
3
Rectal Neoplasms
3
Neoplasms
3
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
LY3023414
2
talazoparib
1
olaparib
1
irinotecan sucrosofate
1
amino-acid, glucose, and electrolyte solution
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Liquid Biopsy
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Radiation
×
90 days
×
Clear all
No trials found.